<DOC>
	<DOCNO>NCT01125683</DOCNO>
	<brief_summary>The purpose study evaluate whether treatment single multiple oral dos AZD1446 1 week effect Quantified Electroencephalography Event-Related Potentials patient Alzheimers Disease . The total treatment period 9 week , divide 5 equally long sub-periods 7 day 4 wash-out period 7 day .</brief_summary>
	<brief_title>To Evaluate Effects AZD1446 , Placebo Donepezil Patients With Alzheimer 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Donepezil</mesh_term>
	<criteria>Clinical diagnosis probable Alzheimer´s Disease Hachinski Ischaemic score &lt; 4 MSE score 18 24 History clinically significant disease dementia Alzheimer´s Disease Current major depressive disorder major psychiatric disorder</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>May 2011</verification_date>
	<keyword>Phase II</keyword>
	<keyword>Alzheimer 's disease</keyword>
	<keyword>EEG</keyword>
	<keyword>cognition</keyword>
	<keyword>pharmacodynamic</keyword>
</DOC>